Investor Tang Capital Partners Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Tang Capital Partners Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 4,502,857 1,641,945
2025-02-14 13G/A OTLK / Outlook Therapeutics, Inc. 2,215,851 1,682,502
2025-02-14 13G/A ALXO / ALX Oncology Holdings Inc. 4,040,800 3,296,883
2024-09-26 13G RPHM / Reneo Pharmaceuticals, Inc. 3,330,000 2,946,260
2024-08-22 13G ALXO / ALX Oncology Holdings Inc. 4,040,800
2024-07-22 13G HLVX / HilleVax, Inc. 4,712,954
2024-07-22 13G AGRX / Agile Therapeutics, Inc. 426,153
2024-04-19 13G MRNS / Marinus Pharmaceuticals, Inc. 4,502,857
2024-03-28 13G OTLK / Outlook Therapeutics, Inc. 2,215,851
2024-02-16 13D/A INVA / Innoviva, Inc. 3,255,026 100
2024-02-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 3,196,446 3,440,345
2024-02-14 13G/A IFRX / InflaRx N.V. 3,000,000 1,873,753
2024-02-14 13G/A ANAB / AnaptysBio, Inc. 2,628,678 1,950,609
2024-02-14 13G/A BNOX / Bionomics Limited - Depositary Receipt (Common Stock) 126,000,000 0
2024-02-14 13G/A BOLT / Bolt Biotherapeutics, Inc. 2,732,250 3,652,244
2024-02-14 13G/A PYXS / Pyxis Oncology, Inc. 3,470,700 0
2024-02-14 13G/A BLPH / Bellerophon Therapeutics, Inc. 1,062,619 0
2024-02-14 13G/A GNFT / Genfit S.A. - Depositary Receipt (Common Stock) 2,643,147 479,441
2024-02-14 13G/A ACRS / Aclaris Therapeutics, Inc. 4,338,155 1,753,335
2024-02-14 13G/A ACET / Adicet Bio, Inc. 2,271,520 5,900,000
2024-02-14 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 0
2024-02-14 13G/A EOLS / Evolus, Inc. 3,038,732 3,097,399
2024-02-14 13G/A AVRO / AVROBIO, Inc. 2,705,000 0
2024-02-14 13G/A THAR / Tharimmune, Inc. 252,549 0
2024-02-14 13G/A RVPH / Reviva Pharmaceuticals Holdings, Inc. 2,266,229 3,098,615
2024-02-14 13G/A TARS / Tarsus Pharmaceuticals, Inc. 2,001,585 2,204,797
2024-02-14 13G/A MEIP / MEI Pharma, Inc. 361,084 326,084
2024-02-14 13G/A CTMX / CytomX Therapeutics, Inc. 3,510,445 6,550,000
2024-02-14 13G/A ELEV / Elevation Oncology, Inc. 1,355,826 4,300,454
2024-02-14 13G/A BCAB / BioAtla, Inc. 3,124,076 2,524,076
2024-02-14 13G/A TCRR / Tcr2 Therapeutics Inc 4,215,864 0
2024-02-14 13G/A ALT / Altimmune, Inc. 2,700,450 2,750,000
2024-02-14 13G/A BLUE / bluebird bio, Inc. 4,635,528 1,700,000
2024-02-14 13G/A KNTE / Kinnate Biopharma Inc. 2,965,715 2,601,647
2024-02-14 13G/A ALGS / Aligos Therapeutics, Inc. 2,816,391 2,189,847
2024-02-14 13G/A QNCX / Quince Therapeutics, Inc. 3,620,000 3,220,000
2024-02-14 13G/A RNAZ / TransCode Therapeutics, Inc. 354,700 0
2024-02-05 13G GRPH / Graphite Bio, Inc. 3,117,843
2024-02-05 13G DTIL / Precision BioSciences, Inc. 6,400,000
2024-02-02 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 4,024,486 0
2024-01-29 13G VTYX / Ventyx Biosciences, Inc. 3,100,000
2024-01-26 13G CRBP / Corbus Pharmaceuticals Holdings, Inc. 426,220
2024-01-12 13D/A INVA / Innoviva, Inc. 3,255,026 3,255,026
2024-01-02 13G/A ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 45,155,180 6,134,975
2023-12-28 13D/A INVA / Innoviva, Inc. 3,101,606 3,255,026
2023-12-26 13D RPHM / Reneo Pharmaceuticals, Inc. 3,330,000
2023-12-07 13G THAR / Tharimmune, Inc. 252,549
2023-11-30 13D LIANY / LianBio - Depositary Receipt (Common Stock) 9,649,019 9,320,746
2023-11-28 13D/A AVIR / Atea Pharmaceuticals, Inc. 3,026,455 4,033,463
2023-11-27 13G KNTE / Kinnate Biopharma Inc. 2,965,715
2023-11-24 13G ACRS / Aclaris Therapeutics, Inc. 4,338,155
2023-11-24 13D INVA / Innoviva, Inc. 3,101,606
2023-11-01 13G LIANY / LianBio - Depositary Receipt (Common Stock) 9,649,019
2023-10-13 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 3,740,341 4,024,486
2023-10-10 13G BNOX / Bionomics Limited - Depositary Receipt (Common Stock) 126,000,000
2023-09-26 13G RNAZ / TransCode Therapeutics, Inc. 354,700
2023-07-13 13G/A ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 45,155,180
2023-06-06 13G AVRO / AVROBIO, Inc. 2,705,000
2023-06-01 13D RAIN / Rain Enhancement Technologies Holdco, Inc. 3,740,341
2023-05-22 13D AVIR / Atea Pharmaceuticals, Inc. 3,026,455
2023-05-05 13G/A TCRR / Tcr2 Therapeutics Inc 2,738,947 4,215,864
2023-05-05 13D/A JNCE / Jounce Therapeutics Inc 5,300,087 10,000
2023-05-01 13G GNFT / Genfit S.A. - Depositary Receipt (Common Stock) 2,643,147
2023-05-01 13G MEIP / MEI Pharma, Inc. 361,084
2023-04-20 13G BOLT / Bolt Biotherapeutics, Inc. 2,732,250
2023-04-17 13G IFRX / InflaRx N.V. 3,000,000
2023-04-07 13D/A JNCE / Jounce Therapeutics Inc 5,300,087 5,300,087
2023-03-31 13G QNCX / Quince Therapeutics, Inc. 3,620,000
2023-03-28 13D/A JNCE / Jounce Therapeutics Inc 5,300,087 5,300,087
2023-03-17 13G BLPH / Bellerophon Therapeutics, Inc. 1,062,619
2023-03-17 13D/A JNCE / Jounce Therapeutics Inc 5,300,087 5,300,087
2023-03-14 13D JNCE / Jounce Therapeutics Inc 5,000,000 5,300,087
2023-03-13 13G ACET / Adicet Bio, Inc. 2,271,520
2023-03-06 13G JNCE / Jounce Therapeutics Inc 5,000,000
2023-02-24 13G ELEV / Elevation Oncology, Inc. 1,355,826
2023-02-21 13G EOLS / Evolus, Inc. 0 3,038,732
2023-02-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,400,000 3,196,446
2023-02-14 13G/A ALGS / Aligos Therapeutics, Inc. 2,358,900 2,816,391
2023-02-14 13G/A ALT / Altimmune, Inc. 2,200,000 2,700,450
2023-02-14 13G/A ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 26,824,625
2023-02-14 13G/A VERU / Veru Inc. 4,130,339 0
2023-02-14 13G/A US8902608624 / Tonix Pharmaceuticals Holding Corp. 4,280,916 4,500,419
2023-02-14 13G/A BLUE / bluebird bio, Inc. 3,721,056 4,635,528
2023-02-14 13G/A ALBO / Albireo Pharma Inc 1,099,516 411,968
2023-02-14 13G/A BCAB / BioAtla, Inc. 2,288,900 3,124,076
2023-02-14 13G/A PYXS / Pyxis Oncology, Inc. 1,981,426 3,470,700
2023-02-14 13G/A HRTX / Heron Therapeutics, Inc. 7,783,688 3,756,694
2023-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 3,101,709 0
2023-02-14 13G/A MTCR / Metacrine Inc 3,041,377 4,250,000
2023-02-14 13G/A TCRR / Tcr2 Therapeutics Inc 2,800,000 2,738,947
2023-02-14 13G/A US45791E1073 / INSPIRATO INC 0
2023-02-14 13G/A CTMX / CytomX Therapeutics, Inc. 3,470,900 3,510,445
2023-02-14 13G/A RVPH / Reviva Pharmaceuticals Holdings, Inc. 1,350,180 2,266,229
2023-02-14 13G/A TARS / Tarsus Pharmaceuticals, Inc. 2,091,753 2,001,585
2023-02-13 13G MGTA / Magenta Therapeutics Inc 5,880,933
2022-12-27 13G US8902608624 / Tonix Pharmaceuticals Holding Corp. 4,280,916
2022-12-27 13G ALGS / Aligos Therapeutics, Inc. 2,358,900
2022-12-19 13G MTCR / Metacrine Inc 3,041,377
2022-11-04 13G PYXS / Pyxis Oncology, Inc. 1,981,426
2022-09-26 13G ALBO / Albireo Pharma Inc 1,099,516
2022-08-24 13D/A LJPC / La Jolla Pharmaceutical Co. 9,959,934 0
2022-07-25 13G CTMX / CytomX Therapeutics, Inc. 3,470,900
2022-07-12 13D/A LJPC / La Jolla Pharmaceutical Co. 9,959,934 9,959,934
2022-06-06 13G VERU / Veru Inc. 4,130,339
2022-06-03 13G BLUE / bluebird bio, Inc. 3,721,056
2022-05-26 13G KALV / KalVista Pharmaceuticals, Inc. 1,400,000
2022-05-13 13G TARS / Tarsus Pharmaceuticals, Inc. 2,091,753
2022-04-28 13G BCAB / BioAtla, Inc. 2,288,900
2022-03-24 13G ALT / Altimmune, Inc. 2,200,000
2022-03-04 13G TCRR / Tcr2 Therapeutics Inc 2,800,000
2022-02-14 13G/A RCKT / Rocket Pharmaceuticals, Inc. 2,965,485 2,531,800
2022-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 3,736,184 3,101,709
2022-02-14 13G/A HRTX / Heron Therapeutics, Inc. 7,639,100 7,783,688
2022-02-14 13G/A LIFE / aTyr Pharma, Inc. 1,063,453 1,113,453
2022-02-14 13G/A VINC / Vincerx Pharma, Inc. 1,030,634
2021-12-02 13D/A LJPC / La Jolla Pharmaceutical Co. 10,126,204 9,959,934
2021-11-26 13D/A APVO / Aptevo Therapeutics Inc. 921,336 0
2021-11-22 13D/A APVO / Aptevo Therapeutics Inc. 1,760,000 921,336
2021-11-19 13D/A ODT / Odonate Therapeutics Inc 16,032,752 12,958,577
2021-09-22 13G CRVS / Corvus Pharmaceuticals, Inc. 3,736,184
2021-09-17 13G LIFE / aTyr Pharma, Inc. 1,063,453
2021-06-21 13D/A APVO / Aptevo Therapeutics Inc. 1,760,000 1,760,000
2021-06-03 13G RVPH / Reviva Pharmaceuticals Holdings, Inc. 1,350,180
2021-05-27 13D/A LJPC / La Jolla Pharmaceutical Co. 9,715,490 10,126,204
2021-02-16 13G/A ANAB / AnaptysBio, Inc. 1,843,814 2,628,678
2021-02-16 13G/A EOLS / Evolus, Inc. 2,635,000 0
2021-02-16 13G/A HRTX / Heron Therapeutics, Inc. 9,749,344 7,639,100
2021-02-16 13G/A RLMD / Relmada Therapeutics, Inc. 1,300,000 200,000
2021-02-09 13D/A APVO / Aptevo Therapeutics Inc. 1,760,000 1,760,000
2020-12-29 13D/A ODT / Odonate Therapeutics Inc 15,670,736 16,032,752
2020-11-19 13G HRTX / Heron Therapeutics, Inc. 9,579,929 9,749,344
2020-11-18 13D/A APVO / Aptevo Therapeutics Inc. 1,760,000 1,760,000
2020-11-06 13D APVO / Aptevo Therapeutics Inc. 1,760,000
2020-09-11 13D/A LJPC / La Jolla Pharmaceutical Co. 9,437,121 9,715,490
2020-09-01 13D/A ODT / Odonate Therapeutics Inc 14,977,889 15,670,736
2020-08-18 13D/A LJPC / La Jolla Pharmaceutical Co. 9,005,474 9,437,121
2020-06-05 13D/A LJPC / La Jolla Pharmaceutical Co. 8,220,575 9,005,474
2020-02-14 13G/A CLRB / Cellectar Biosciences, Inc. 637,715 0
2020-02-14 13G/A RLMD / Relmada Therapeutics, Inc. 780,847 1,300,000
2020-02-14 13G/A EOLS / Evolus, Inc. 1,925,000 2,635,000
2020-01-14 13D/A LJPC / La Jolla Pharmaceutical Co. 5,236,893 8,220,575
2020-01-07 13D/A HRTX / Heron Therapeutics, Inc. 7,967,078 9,579,929
2019-11-22 13G ANAB / AnaptysBio, Inc. 1,843,814
2019-11-18 13G EOLS / Evolus, Inc. 1,925,000
2019-10-31 13G RLMD / Relmada Therapeutics, Inc. 780,847
2019-06-28 13D/A ODT / Odonate Therapeutics Inc 14,157,914 14,977,889
2019-05-28 13G CLRB / Cellectar Biosciences, Inc. 637,715
2019-03-12 13D/A ODT / Odonate Therapeutics Inc 13,851,042 14,157,914
2019-02-14 13G/A RCKT / Rocket Pharmaceuticals, Inc. 2,965,485
2019-01-14 13D/A LJPC / La Jolla Pharmaceutical Co. 4,186,893 5,236,893
2018-11-09 13D/A ODT / Odonate Therapeutics Inc 12,492,338 13,851,042
2018-09-13 13D/A HRTX / Heron Therapeutics, Inc. 8,762,818 7,967,078
2018-08-24 13D/A ODT / Odonate Therapeutics Inc 12,492,338 12,492,338
2018-08-23 13D/A ODT / Odonate Therapeutics Inc 12,492,338
2018-03-20 13D/A LJPC / La Jolla Pharmaceutical Co. 3,668,419 4,186,893
2018-03-01 13D/A LJPC / La Jolla Pharmaceutical Co. 3,326,165 3,668,419
2018-02-15 13G/A 451731103 / Ignyta, Inc. 1,390,802 1,390,802
2018-02-14 13G/A 451731103 / Ignyta, Inc. 3,972,800 1,390,802
2018-01-16 13G RCKT / Rocket Pharmaceuticals, Inc. 2,665,485
2018-01-16 13G RCKT / Rocket Pharmaceuticals, Inc. 2,665,485
2017-12-18 13D ODT / Odonate Therapeutics Inc 12,202,338
2017-11-22 13D/A CYCC / Bio Green Med Solution, Inc. 559,900 336,747
2017-03-06 13D/A LJPC / La Jolla Pharmaceutical Co. 3,071,130 3,326,165
2017-02-27 13D/A CYCC / Bio Green Med Solution, Inc. 359,900 559,900
2017-01-24 13D/A HRTX / Heron Therapeutics, Inc. 6,292,229 8,762,818
2016-09-16 13D CYCC / Bio Green Med Solution, Inc. 300,000 359,900
2016-08-19 13G CYCC / Bio Green Med Solution, Inc. 300,000
2016-08-10 13D/A HRTX / Heron Therapeutics, Inc. 6,527,743 6,292,229
2016-05-09 13G 451731103 / Ignyta, Inc. 3,972,800
2016-04-14 13D/A HRTX / Heron Therapeutics, Inc. 5,258,847 6,527,743
2016-03-07 13D/A LJPC / La Jolla Pharmaceutical Co. 2,840,970 3,071,130
2016-02-16 13G/A PHIO / Phio Pharmaceuticals Corp. 0
2015-08-21 13D/A LJPC / La Jolla Pharmaceutical Co. 2,554,970 2,840,970
2015-06-24 13D/A LJPC / La Jolla Pharmaceutical Co. 2,334,970 2,554,970
2015-06-12 13D/A HRTX / Heron Therapeutics, Inc. 5,258,847
2015-05-15 13D/A LJPC / La Jolla Pharmaceutical Co. 2,334,970
2015-01-27 13G/A PHIO / Phio Pharmaceuticals Corp. 2,236,438
2015-01-27 13G/A MRTX / Mirati Therapeutics, Inc. 603,920
2015-01-27 13G/A ACHV / Achieve Life Sciences, Inc. 500,000
2014-12-16 13D/A LJPC / La Jolla Pharmaceutical Co. 2,143,805
2014-09-30 13D/A LJPC / La Jolla Pharmaceutical Co. 1,911,462
2014-09-02 13D/A LJPC / La Jolla Pharmaceutical Co. 1,741,907
2014-08-07 13D LJPC / La Jolla Pharmaceutical Co. 1,741,907
2014-07-29 13G/A LJPC / La Jolla Pharmaceutical Co. 1,741,067
2014-06-27 13D/A HRTX / Heron Therapeutics, Inc. 4,968,927
2014-01-16 13G/A CYCC / Bio Green Med Solution, Inc. 0
2014-01-16 13G/A ANTH / Anthera Pharmaceuticals, Inc. 0
2014-01-16 13G/A VNDA / Vanda Pharmaceuticals Inc. 0
2014-01-16 13G/A SUPN / Supernus Pharmaceuticals, Inc. 471,764
2014-01-16 13G/A PHIO / Phio Pharmaceuticals Corp. 1,298,094
2014-01-16 13G MRTX / Mirati Therapeutics, Inc. 774,375
2014-01-16 13G/A LJPC / La Jolla Pharmaceutical Co. 468,214
2014-01-16 13G/A ACHV / Achieve Life Sciences, Inc. 747,614
2013-11-22 13D/A HRTX / Heron Therapeutics, Inc. 89,079,785
2013-05-09 13D/A HRTX / Heron Therapeutics, Inc. 71,579,785
2013-05-06 13G SUPN / Supernus Pharmaceuticals, Inc. 2,264,470
2013-04-02 13G/A CYCC / Bio Green Med Solution, Inc. 765,198
2013-03-18 13G PHIO / Phio Pharmaceuticals Corp. 32,677,161
2013-02-14 13G/A PRTK / Paratek Pharmaceuticals Inc. 0
2013-02-14 13G/A ASRT / Assertio Holdings, Inc. 2,475,016
2013-02-14 13G/A ALXA / Alexza Pharmaceuticals, Inc. 823,972
2013-02-14 13G/A VNDA / Vanda Pharmaceuticals Inc. 1,808,525
2013-02-14 13G/A HZNP / Horizon Therapeutics Plc 2,828,720
2013-02-14 13G/A SPPI / Spectrum Pharmaceuticals, Inc. 0
2013-02-14 13G/A 662,117,262
2013-02-14 13G/A CTIC / CTI BioPharma Corp 0
2013-02-14 13G/A LJPC / La Jolla Pharmaceutical Co. 1,507,319
2013-02-14 13G/A ACHV / Achieve Life Sciences, Inc. 869,231
2013-01-25 13G/A ANTH / Anthera Pharmaceuticals, Inc. 11,466,674
2013-01-02 13G CYCC / Bio Green Med Solution, Inc. 631,561
2012-10-09 13G CTIC / CTI BioPharma Corp 6,911,221
2012-09-21 13G HZNP / Horizon Therapeutics Plc 5,657,440
2012-07-30 13G ANTH / Anthera Pharmaceuticals, Inc. 5,500,000
2012-07-30 13D/A HRTX / Heron Therapeutics, Inc. 71,579,785
2012-06-20 13D/A RDEA / Ardea Biosciences, Inc. 0
2012-05-11 13D/A HRTX / Heron Therapeutics, Inc. 61,555,975
2012-05-04 13G PRTK / Paratek Pharmaceuticals Inc. 1,750,000
2012-04-25 13D/A RDEA / Ardea Biosciences, Inc. 4,115,172
2012-04-23 13G SPPI / Spectrum Pharmaceuticals, Inc. 4,577,895
2012-04-20 13G VNDA / Vanda Pharmaceuticals Inc. 1,951,252
2012-03-22 13G ACHV / Achieve Life Sciences, Inc. 807,100
2012-02-21 13G ALXA / Alexza Pharmaceuticals, Inc. 11,000,000
2012-02-14 13G/A OPTR / Optimer Pharmaceuticals Inc 455,205
2012-02-14 13G/A ASRT / Assertio Holdings, Inc. 4,668,145
2012-02-14 13G/A ANIP / ANI Pharmaceuticals, Inc. 3,176,881
2012-02-14 13G/A SVRA / Savara Inc. 591,250
2012-02-14 13G/A SLS / SELLAS Life Sciences Group, Inc. 0
2012-02-14 13G/A GNTA / Genenta Science S.p.A. - Depositary Receipt (Common Stock) 195,388,893
2012-02-14 13G/A LJPC / La Jolla Pharmaceutical Co. 8,327,088
2012-02-13 13G MNKD / MannKind Corporation 8,698,763
2012-02-03 13D/A RDEA / Ardea Biosciences, Inc. 4,127,172